Does CBD normalize brain activity patterns altered by psychosis?
A double-blind crossover fMRI study found that a single 600 mg CBD dose partially normalized altered brain activation patterns in psychosis patients, shifting activity toward levels seen in healthy controls.
Quick Facts
What This Study Found
Psychosis patients on placebo showed altered prefrontal activation during verbal encoding and altered mediotemporal and prefrontal activation during recall, along with greater hippocampal-striatal connectivity. CBD attenuated these dysfunctions, producing activation patterns intermediate between the placebo condition and healthy controls. CBD also reduced hippocampal-striatal functional connectivity.
Key Numbers
15 psychosis patients; 19 healthy controls; 600 mg CBD single dose; brain activation under CBD shifted toward healthy control patterns in mediotemporal, prefrontal, and striatal regions
How They Did This
Double-blind, randomized, placebo-controlled, within-subject crossover design. 15 psychosis patients scanned with fMRI on two days (CBD 600 mg vs placebo). 19 healthy controls scanned without drug for comparison. Task: verbal paired associate learning.
Why This Research Matters
This study provides neuroimaging evidence for how CBD may exert antipsychotic effects, showing it partially corrects the specific brain activation patterns that differ between psychosis patients and healthy individuals.
The Bigger Picture
Together with the companion glutamate study, this work builds a picture of CBD acting through multiple brain mechanisms simultaneously. Normalizing both neurochemistry and functional connectivity could explain why CBD shows antipsychotic promise despite working differently from existing drugs.
What This Study Doesn't Tell Us
Small sample (15 patients, 13 completed scanning). Single-dose design. Healthy controls did not receive any drug, preventing direct comparison of CBD effects in healthy brains. Trend-level symptom reduction only.
Questions This Raises
- ?Does chronic CBD treatment produce sustained normalization of brain activation?
- ?Would these effects be stronger or weaker in drug-naive patients?
- ?How do these fMRI changes relate to the glutamate changes observed in the companion study?
Trust & Context
- Key Stat:
- 15 patients, brain activity shifted toward normal
- Evidence Grade:
- Double-blind crossover RCT with fMRI, but very small sample and single-dose design.
- Study Age:
- Published in 2021; companion study to the glutamate findings (RTHC-03390).
- Original Title:
- Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.
- Published In:
- Psychological medicine, 51(4), 596-606 (2021)
- Authors:
- O'Neill, Aisling(5), Wilson, Robin(4), Blest-Hopley, Grace(10), Annibale, Luciano, Colizzi, Marco, Brammer, Mick, Giampietro, Vincent, Bhattacharyya, Sagnik
- Database ID:
- RTHC-03391
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
What brain changes does psychosis cause?
Psychosis patients showed altered activation in prefrontal and mediotemporal regions during memory tasks, along with increased connectivity between the hippocampus and striatum compared to healthy controls.
How did CBD affect these brain changes?
CBD partially corrected the altered activation patterns, shifting brain activity to a level intermediate between the abnormal placebo condition and healthy control patterns. It also reduced the excessive hippocampal-striatal connectivity.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03391APA
O'Neill, Aisling; Wilson, Robin; Blest-Hopley, Grace; Annibale, Luciano; Colizzi, Marco; Brammer, Mick; Giampietro, Vincent; Bhattacharyya, Sagnik. (2021). Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.. Psychological medicine, 51(4), 596-606. https://doi.org/10.1017/S0033291719003519
MLA
O'Neill, Aisling, et al. "Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis.." Psychological medicine, 2021. https://doi.org/10.1017/S0033291719003519
RethinkTHC
RethinkTHC Research Database. "Normalization of mediotemporal and prefrontal activity, and ..." RTHC-03391. Retrieved from https://rethinkthc.com/research/o-neill-2021-normalization-of-mediotemporal-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.